Insulet | PODD - أصول متداولة





أصول متداولة تغيير تاريخ
Abbott USD 25.51B 488M 2026-03
Align Technology USD 2.66B 7.62M 2026-06
AtriCure USD 345.53M 31.84M 2026-06
Baxter International USD 6.99B 142M 2026-06
Becton, Dickinson and Co. USD 8.14B 127M 2026-06
Boston Scientific USD 7.97B 712M 2026-06
Cardinal Health USD 38.75B 689M 2026-06
Cooper Companies USD 2.3B 166M 2026-03
Dexcom USD 4.09B 245.1M 2026-06
Edwards Lifesciences USD 6.82B 590.2M 2026-06
Eli Lilly USD 64.67B 9.84B 2026-06
Globus Medical USD 2.22B 17.39M 2026-06
ICU Medical USD 1.21B 2.34M 2026-06
Inogen USD 203.72M 594K 2025-09
Insulet USD 1.85B 139.6M 2026-06
Integra LifeSciences USD 1.19B 19.46M 2026-06
J&J USD 59.77B 601M 2026-06
Medtronic USD 24.79B 716M 2026-03
Merit Medical Systems USD 1.11B 10.46M 2026-06
Roche Holding CHF 35.44B 3.29B 2026-06
Solventum Corp USD 3.74B 158M 2026-06
Stryker USD 14.42B 1.08B 2026-06
Tandem Diabetes Care USD 804.64M 82.46M 2026-06
Teleflex USD 1.88B 16.21M 2026-06
West Pharmaceutical Services USD 1.81B 19.3M 2026-06
Zimmer Biomet Holdings USD 5.1B 134.2M 2026-06